Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
HIF-1α: a master regulator of innate host defenses?
Kol A. Zarember, Harry L. Malech
Kol A. Zarember, Harry L. Malech
Published July 1, 2005
Citation Information: J Clin Invest. 2005;115(7):1702-1704. https://doi.org/10.1172/JCI25740.
View: Text | PDF
Commentary

HIF-1α: a master regulator of innate host defenses?

  • Text
  • PDF
Abstract

In the days following infection, when the human body develops and refines antibodies and prepares to mount an adaptive immune response, the bulwark of innate host defense against microbial infection is the polymorphonuclear leukocyte (PMN). PMNs seek out, identify, engulf, and sterilize invading microbes using both O2-dependent and O2-independent antimicrobial systems. A decrease in PMN numbers or function caused by immunosuppression or disease increases the risk of infection. In this issue of the JCI, Peyssonnaux et al. identify a novel and essential role for hypoxia-inducible factor–1α in regulating several important PMN functions relevant to host defense, including transcription of cationic antimicrobial polypeptides and induction of NO synthase.

Authors

Kol A. Zarember, Harry L. Malech

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
HIF-1α regulates several important PMN functions relevant to host defens...
HIF-1α regulates several important PMN functions relevant to host defense during both normoxia and hypoxia. (A) During normoxia, O2-dependent proline hydroxylases modify HIF-1α proline residues 402 and 564. Asparagine 803 is hydroxylated by FIH, which decreases HIF-1α interaction with the p300/CBP transcriptional coactivators. The hydroxylated prolines are recognized by vHL, a component of a ubiquitin ligase complex that ubiquitinates (Ub) HIF-1α and thereby targets it for proteosomal degradation. (B) During hypoxia and/or bacterial infection, when proline hydroxylases are not active, HIF-1α regulates transcription at HREs by accumulating and binding to HIF-1β and p300/CBP, which results in transcription of hypoxia-inducible genes involved in angiogenesis, glucose transport and metabolism, erythropoiesis, inflammation, apoptosis, and cellular stress. EPO, erythropoietin.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts